Stavanger University Hospital
Stavanger, NO-4011, Norway
NCT Number: NCT01201486
To evaluate the percentage of severe heart defect diagnosed with the use of color Doppler at a routine fetal scan in the second trimester of pregnancy
Looking for future studies?
Notify MeFemale
Observational
Stavanger, NO-4011, Norway
Almost all women in Norway have a routine ultrasound examination in the second trimester, however, the detection rate of heart defect are only around 50%. In this study we use color Doppler at three different levels in the fetal heart; the four chamber view, the outlet of the aorta on on the level of the great arteries.
All heart defects at delivery are recorded and compared with the ultrasound findings.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2nd trimester
The number of *fetuses with* heart defects detected by color Doppler in the second trimester was compared to the number of *fetuses with* major heart defects detected at birth.
Helse Stavanger HF
Other Gov
Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03822442
Cardiac Imaging Techniques, Cardiomegaly
Washington D.C., District of Columbia, United States
View Trial DetailsNCT01845402
Cardiovascular Abnormalities, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT02320669
Cardiovascular Abnormalities, Cardiovascular Diseases
Los Angeles, California, United States
View Trial DetailsNCT00740870
Cardiovascular Abnormalities, Cardiovascular Diseases
Miami, Florida, United States
View Trial Details